Overview
EHC market data
Price History
EHC price chart
Valuation & Profitability
- P/E (TTM)
- 20.02 Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- $5.54 Diluted earnings per share over the trailing twelve months.
- Beta
- 0.77 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- 0.7% Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- 10.0% Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $92.77 – $127.99 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $12.2B · P/B 4.38 · P/S 2.01.
Company News
8-K filing — Encompass Health Corp (EHC)SEC EDGAR · Aug 13, 2026, 8:39 PM
TD Cowen Maintains Buy on Encompass Health, Raises Price Target to $140Benzinga · Aug 10, 2026, 3:28 PM
UBS Maintains Buy on Encompass Health, Raises Price Target to $155Benzinga · Aug 7, 2026, 11:37 PM
Truist Securities Maintains Buy on Encompass Health, Raises Price Target to $150Benzinga · Aug 7, 2026, 1:17 PM
Barclays Maintains Overweight on Encompass Health, Raises Price Target to $144Benzinga · Aug 6, 2026, 1:30 PM
Encompass Health shares are trading higher after the company reported better-than-expected Q2 financial results and raised its FY26 guidance.Benzinga · Aug 6, 2026, 11:28 AM
Encompass Health Raises FY2026 Adj EPS Guidance from $5.89-$6.11 to $6.02-$6.25 vs $6.00 Est; Raises FY2026 Sales Guidance from $6.375B-$6.470B to $6.410B-$6.490B vs $6.421B EstBenzinga · Aug 5, 2026, 9:02 PM
Encompass Health Q2 Adj. EPS $1.55 Beats $1.48 Estimate, Sales $1.597B Beat $1.571B EstimateBenzinga · Aug 5, 2026, 8:22 PM
Encompass Health Increases Quarterly Dividend From $0.19 Per Share To $0.21 Per ShareBenzinga · Jul 23, 2026, 12:08 PM
Healthcare Added 35,200 Jobs—3 Stocks Positioned to BenefitInvesting.com · Jun 15, 2026, 6:15 PM